(Date:10/13/2008)... -- Integrated Medical,Systems, Inc., a medical te...rated products for critical care, announced today .... Food and Drug Administration (FDA) to market,its...U)., "FDA clearance of the MedEx 1000 is a major ...emonstrate the economic and clinical value of,inte...
(Date:10/13/2008)...ly life, survey shows, PORTLAND, Ore., Oct. 13 /P...ers of people living with psoriasis say the diseas...g to a National Psoriasis,Foundation 2008 survey r...h psoriasis and psoriatic arthritis,also revealed ...hapes their,feelings about themselves and affects ...
(Date:10/13/2008)...tes and Washington, D.C., WASHINGTON, Oct. 13 /PR...ay announced a new course. Coping With Deployments...s now available. The course, offered free of,charg...ty, Reserve and,National Guard forces, as well as ... is offered in sixteen states (Ala., Ark., Calif.,...
(Date:10/13/2008)...ws Three Women - Doctors, Working M...sk Babies in Their OB/GYN Practice -, SILVER SPRI...is going,back into the delivery room with the anti...VER ME. The breakout series follows the careers an... and Alane Park -- best,friends who became partner...
Breaking Medicine News(10 mins):Health News:Integrated Medical Systems Receives FDA Clearance for World's First 'Suitcase' Intensive Care Unit 2Health News:Integrated Medical Systems Receives FDA Clearance for World's First 'Suitcase' Intensive Care Unit 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:American Red Cross Offering Free Class to Help Military Families Cope With the Stress of Deployments 2Health News:Discovery Health is Expecting! Season Two of DELIVER ME is Due on Tuesday, November 11 at 10 PM ET/PT 2Health News:Discovery Health is Expecting! Season Two of DELIVER ME is Due on Tuesday, November 11 at 10 PM ET/PT 3...llapsed on a family in Karawal Nagar area of north...n and two adults and injuring four others on Satur... the wall of a school building, which had been con...uty commissioner of police R.L Meena said that the...
...inst cancer focusing at the molecular and genetic ...cerous cells is coming under increasing scrutiny./...na at Chapel Hill have demonstrated that these sup...the ultimate development and aggressiveness of can...
... University of Michigan and the Mayo Clinic say th...t not be very effective in women who inherit a com...gene has the ability to influence the levels of a ... tamoxifen against breast cancer. The study which ...
...are encouraging stereotype body images among their...he Florida State University. Even three year olds ...encouraged to eat well and grow physically,// whil...others were of the opinion that their daughters at...
Other Medicine News:Health News:Cancer Cells Trigger Supporting Cells to Turn Cancerous 2(Date:10/12/2008)...GTON, Oct. 12 /- Boston,Sci...results from an analysis,of nearly 7,500 patients ...e designed to confirm the performance of the TAXUS... System in real-world practice. The,two-year poole...clinical,restenosis in patients with diabetes as e...
(Date:10/10/2008)...- Boston Scientific,Corpora... the Company,s major,events and press announcement...) twentieth annual Transcatheter Cardiovascular Th...from October 12 to 17 in Washington, D.C., Boston...ety and,efficacy data on its TAXUS(R) Express2(TM)...
(Date:10/9/2008)...s Expected in November 2008, BOTHELL, Wash., Oct....mex: DDD ) announced today the completion of pati...ee pivotal trials to evaluate the safety and,effic... (ER) ibuprofen for,the over-the-counter (OTC) mar...s from this pivotal trial in November 2008. Ibupro...
(Date:10/8/2008)...nform Treatments for Spinal Cord, Other Nerve,Inju...re/ -- A protein that enables,nerve cells to commu...ling,the developing nervous system. Research into ... among nerve cells may provide a basis for eventua...heir nervous system,including spinal cord injury....
Breaking Medicine Technology:TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA 2172 1Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA 2172 2Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA 2172 3Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update 2170 1TriWest Contributes 2475 000 to Agencies Supporting California Guardsmen 8177 1TriWest Contributes 2475 000 to Agencies Supporting California Guardsmen 8177 2TriWest Contributes 2475 000 to Agencies Supporting California Guardsmen 8177 3Vanda Presents Phase III Iloperidone Efficacy Data 1052 1Vanda Presents Phase III Iloperidone Efficacy Data 1052 2Vanda Presents Phase III Iloperidone Efficacy Data 1052 3Vanda Presents Phase III Iloperidone Efficacy Data 1052 4...- Phase I data from XL880, Phase II data from XL99...poster sessions -, SOUTH SAN FRANCISCO, May 30, 20...ced today that data from clinical trials of,the co...will be,presented at the 2007 American Society of ...being held June 1 to 5 in Chicago,Illinois. , , ...
...Investigational Drug Being Pursued for the Treatme...2007 /PRNewswire-FirstCall/ --,Neurobiological Tec...tion of new analysis of data from prior clinical t...pment of their,investigational drug, Viprinex (anc...t the 16th annual European Stroke Congress in,Glas...
Other Medicine Technology:Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 2Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 3Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 4...ts make us a leader in this field. With standard a...y laboratory, our Infectious Disease ELISA product...sistency. Our Infectious Disease ELISA menu includ...erological assays including ToRCH, EBV, H. pylori ...
...ts make us a leader in this field. With standard a...y laboratory, our Infectious Disease ELISA product...sistency. Our Infectious Disease ELISA menu includ...erological assays including ToRCH, EBV, H. pylori ...
...ts make us a leader in this field. With standard a...y laboratory, our Infectious Disease ELISA product...sistency. Our Infectious Disease ELISA menu includ...erological assays including ToRCH, EBV, H. pylori ...
...ts make us a leader in this field. With standard a...y laboratory, our Infectious Disease ELISA product...sistency. Our Infectious Disease ELISA menu includ...erological assays including ToRCH, EBV, H. pylori ...
Medicine Products: